With new Gene and Cell Therapy institute, MGB is staking its claim in the biotech industry

"We’re trying to take the best of the VC world and the best of the academic world and merge it together in a way that is going to differentiate it from other gene therapy institutes," said Nathan Yozwiak, head of research at GCTI.